Deal-making activity kept its pace for the two weeks ended June 29, with @TakedaPharma and @Merck among those striking licensing deals, according to @SPGMarketIntel data
https://t.co/IOs13eGsPG 
$MRK https://t.co/XeGtqPB6kB